comparemela.com

The partners will leverage IBM’s foundation model technologies to help identify antibodies designed to target and neutralize various disease-causing agents or cells.

Related Keywords

Germany ,German ,Scala Biodesign ,Andrew Nixon ,Pfizer ,Ibm ,Astrazeneca ,Boehringer Ingelheim ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.